Background: Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive, fibrotic interstitial
pneumonia of unknown etiology with a poor prognosis. No serum biomarker for predicting …

Background and objective Idiopathic pulmonary fibrosis (IPF) is a progressive interstitial
lung disease with a poor prognosis. There are no established serum biomarkers for …

Background: Neutrophilic inflammation is a predominant characteristic of idiopathic
pulmonary fibrosis (IPF). S100 Calcium-Binding Protein A9 (S100A9) is a neutrophil-derived …

RATIONALE Neutrophilic inflammation is a predominant characteristic of idiopathic
pulmonary fibrosis (IPF). S100 Calcium-Binding Protein A9 (S100A9) is a neutrophil-derived …

Background Fibroblast dysfunction is the main pathogenic mechanism of idiopathic
pulmonary fibrosis (IPF). S100 calcium-binding protein A4 (S100A4) plays critical roles in …

Background Neutrophilic inflammation is a characteristic feature of idiopathic pulmonary
fibrosis (IPF). S100 calcium-binding protein A9 (S100A9) is a neutrophil-derived protein …

Abstract Background S100A12, S100A8, and S100A9 are inflammatory disease biomarkers
whose functional significance in idiopathic pulmonary fibrosis (IPF) remains unclear. We …

論文の内容の要旨 [はじめに] 特発性肺線維症 (IPF) は, 肺の不可逆的な線維化を特徴とする予後
不良な間質性肺疾患 (ILD) である. 抗線維化薬は重要な治療選択肢であり, 予後改善のためには …

Background Acute exacerbation of idiopathic pulmonary fibrosis (AE-IPF) is a devastating
and life-threatening condition during its clinical course. Biomarkers for precisely anticipating …

BACKGROUND: Idiopathic pulmonary fibrosis (IPF) is a specific form of chronic, progressive
fibrosing interstitial pneumonia of unknown cause, and the prognosis remains poor. On the …